The efficacy of EPA on the clinical outcome in patients with arteriosclerosis obliterans undergoing endvascular treatment: Prospective study
Not Applicable
Recruiting
- Conditions
- arteriosclerosis obliterans
- Registration Number
- JPRN-UMIN000026607
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with aortic diseae, BK disease, otherresidual vascular disease, formely taking EPA,EVT failure,use of DES,and contraindication of EPA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major lower limbs events(revascularization, amputation)
- Secondary Outcome Measures
Name Time Method Fontaine classification,Rutherford classification,6MW,ABI(Ankle Brachial Pressure Index),TBI(toe brachial pressure index),SPP(skin perfusion pressure),Major cardiovascular events